Vitamin E succinate (VES) shows antiproliferative activity in tumour cell lines of different organs, which is unrelated to the antioxidant activity of vitamin E. We examined the ef®cacy of vitamin E succinate in human prostate carcinoma cell lines, paying particular attention to the induction of apoptotic cell death.
Vitamin E succinate (VES) shows antiproliferative activity in tumour cell lines of different organs, which is unrelated to the antioxidant activity of vitamin E. We examined the ef®cacy of vitamin E succinate in human prostate carcinoma cell lines, paying particular attention to the induction of apoptotic cell death.
Method
Cytotoxicity of VES against the cell lines LNCaP, DU145 and PC5 was measured in continuously rising concentrations from 10 to 100 mgaml VES by a MTT assay. The VES concentrations which resulted in a 50% cell death rate (IC50 values) were evaluated. In the cell line LNCaP, the relative amount of apoptotic cells after a 24 h incubation in increasing VES concentrations was measured by annexin V staining combined with FACS analysis and the concentration of fragmented DNA by TUNEL assay and ELISA.
Results
VES showed a clear antiproliferative activity in all three cell lines. The IC50 values for LNCaP, DU14 and PC3 were 17.2 AE 1.7 mgaml, 24.8 AE 3.8mgaml and 28.3 AE 5.7 mgaml, respectively. After an incubation of LNCaP cells with 10, 20 and 40 mgaml VES for 24 h, the relative amount of apoptotic cells increased from 11.5% to 32.5, 46.6 and 62.8% in the controls. The high rate of apoptosis was con®rmed by the TUNEL assay.
Conclusion

VES is effective in human prostate carcinoma cells in vitro.
The resulting cell death is mediated by apoptosis. VES could be used, therefore, in prophylaxis and therapy for prostate cancer.
